Urticaria Associated with Hyper-IgE in a Patient with Psoriasis Undergoing Treatment with Efalizumab

By Saraceno Rosita   Scotto Gea   Chiricozzi Andrea   Chimenti Sergio  

Acta Dermato-Venereologica, Vol. 89, Iss. 4, 2009-06 ,pp. : 412-413

Medical Journals Limited

Access to resources Recommend Favorite

Recurrent Angioedema Associated with Efalizumab

By Mallbris Lotus   von Bergen Fredrik   van Hage Marianne   Ståhle Mona  

Acta Dermato-Venereologica, Vol. 89, Iss. 6, 2009-10 ,pp. : 665-666

Medical Journals Limited

Access to resources Recommend Favorite

Efalizumab, a reversible T-cell modulator for psoriasis

By Shear Neil   Langley Richard   Ho Vincent  

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 1, 2005-12 ,pp. : 4-9

Springer Publishing Company

Access to resources Recommend Favorite

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis

By Papp Kim   Ho Vincent   Langley Richard   Lynde Charles   Poulin Yves   Shear Neil   Toole John   Zip Catherine  

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 1, 2005-12 ,pp. : 26-32

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Efficacy of Efalizumab in Patients With Chronic Plaque Psoriasis: Results From Three Randomized Placebo-Controlled Phase III Trials: Part I

By Pariser David   Gordon Kenneth   Papp Kim   Leonardi Craig   Kwon Paul   Compton Peter   Rundle Amy   Walicke Patricia   Lebwohl Mark  

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 6, 2005-12 ,pp. : 303-312

Springer Publishing Company

Access to resources Recommend Favorite